Last updated 25/6/20
ARMA is working to support our members to share information and respond effectively to the coronavirus outbreak. Patient organisations are working to ensure people have the advice they need related to their condition or medication. Our professional members are working to ensure healthcare professionals have access to the information they need about the virus and also how to continue to provide healthcare support in the current situation.
ARMA is signposting the most relevant information we can find and will update this page as new information becomes available. It includes information for professionals, patients, parents and guidance for Wales and Scotland.
General advice about social distancing including groups who may be more at risk. (Updated 31/5/20)
Information for professionals
NHSE Speciality guides including:
- Management of rheumatology patients which includes more information about levels of risk for different groups (v. 2 posted 14 April)
- Management of trauma and orthopaedic patients (v. 2 posted 14 April)
- Management of patients requiring spinal surgery (v. 2 posted 15 April)
- perioperative care of people with fragility fractures
- Urgent and emergency musculoskeletal conditions in children (under 16) requiring onward referral
- Urgent and Emergency Musculoskeletal Conditions Requiring Onward Referral – to help primary or community care practitioners recognise serious pathology which requires emergency or urgent referral to secondary care in patients who present with new or worsening musculoskeletal (MSK) symptoms.
- Management of patients with musculoskeletal and rheumatic conditions on corticosteroids
These can all be found here:
Operating framework for urgent and planned services within hospitals (14 May)
Re-starting non-urgent trauma and orthopaedic care guidance from British Orthopaedic Association
NICE COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders.
Management of patients with musculoskeletal and rheumatic conditions who: are on corticosteroids; require initiation of oral/IV corticosteroids; require a corticosteroid injection (16/6/20)
Information to help healthcare professionals manage osteoporosis patients taking denosumab (Prolia)
Guidance and updates for GPs: Highest clinical risk patients (23 June) Includes text of letter being sent to those who are shielding.
Identifying high risk patients who should be shielding – There is information on the BSR website about how this will be done in relation to rheumatology including a template of the letter patients will receive.
COVID-19 – ‘shielding’ guidance for children and young people
Information in the NHS website for patients about shielding. (Updated 22/6/20)
Community MSK services
Prioritisation within community services guidance – which services should stop, continue or change their provision, including podiatry, rehab, therapy and MSK services. Covers both children and young people services and adult and older people services. Includes a link to the new hospital discharge service requirements to free up beds and will be a priority for some of the services listed above.
The Stanford Hall consensus statement for post-COVID-19 rehabilitation
Guidance from the CSP on implementing remote consultations
COVID-19 – talking to children and families about returning to school: guiding principles
Information about NICE rapid guidelines on the active management of COVID-19 infection. NICE are also reviewing guidance on ibuprofen and other non-steroidal anti-inflammatory drugs in relation to impact on covid-19 illness.
Guidance on infection prevention and control for COVID-19
Guidance on Vitamin D supplements for people getting out less due to shielding, isolating or lockdown.
Information for patients
A risk calculator for rheumatology patients to assess their risk and whether you should be isolating or shielding.
FAQs for patients on resuming surgical services
Many patient organisations have helplines and web-based information.
Arthritis Action: https://www.arthritisaction.org.uk/covid-19-advice/
Fibromyalgia UK: http://www.fmauk.org/coronavirus
Hypermobility Syndromes Association: https://www.hypermobility.org/news/covid19-resources
Lupus UK: https://www.lupusuk.org.uk/coronavirus/
National Axial Spondyloarthritis Society (NASS): https://nass.co.uk/managing-my-as/covid19-coronavirus/
National Rheumatoid Arthritis Society (NRAS): https://www.nras.org.uk/coronavirus (info page);
and Here For You, a new service that allows you to arrange a callback with someone with RA who understands you: https://www.nras.org.uk/here-for-you
Psoriasis Association: https://www.psoriasis-association.org.uk/psoriasis-and-treatments/covid-19-information
Royal Osteoporosis Society: https://theros.org.uk/information-and-support/coronavirus-and-osteoporosis
Scleroderma & Raynaud’s UK (SRUK): https://www.sruk.co.uk/about-us/news/novel-coronavirus-covid-19-advice-our-community/
Versus Arthritis: https://www.versusarthritis.org/news/2020/march/coronavirus-covid-19-what-is-it-and-where-to-go-for-information/
Information for patients and parents of children and young people
From SPARN (Scottish Paediatric and Adolescent Rheumatology Network)
CCCA Kids with Arthritis incorporating JIA Matters facebook group
Great Ormond Street Hospital advice for parents of vulnerable children and young people – useful practical advice on shielding for a child.
Resources for young people – specifically about shielding and social distancing and developed with input of children/young people.
Information for Wales
Guidance for professionals (nothing MSK specific)
COVID-19 High risk shielded patient list identification methodology (note different methodology for rheumatology from England and guidance below contains more up to date list)
Guidance on shielding and protecting people defined on medical grounds as extremely vulnerable from coronavirus (COVID-19). (updated 1 June).
https://gov.wales/get-coronavirus-support-extremely-vulnerable-person – contact your local authority
Shielding guidance in Wales did not change from 22 June:
Information for Scotland
Guidance for healthcare professionals